[Bipolar depression].
M
M
Leboyer
P-M
PM
Llorca
D000927:Anticonvulsants / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D002908:Chronic Disease; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D003299:Cooperative Behavior; D003937:Diagnosis, Differential; D006801:Humans; D033183:Interdisciplinary Communication; D016651:Lithium Carbonate / Q000627:therapeutic use; D010348:Patient Care Team; D011379:Prognosis; D000092864:Suicide Prevention
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D016651:Lithium Carbonate